GO:0006370 7-methylguanosine mRNA capping: mRNA Stability and Translation Initiation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006370 (7-methylguanosine mRNA capping) describes the enzymatic addition of an inverted 7-methylguanosine (m7G) cap to the 5' end of nascent mRNA via a 5'-5' triphosphate bridge.
• The cap is essential for mRNA stability, nuclear export, and efficient translation initiation, and its loss leads to transcript degradation.
• Core capping enzymes include RNA triphosphatase, RNA guanylyltransferase, and RNA guanine-N7 methyltransferase, which act in a conserved three-step reaction.
• Viruses and parasites rely on capping machinery for immune evasion and survival, making it a target for antiviral and antiparasitic research.
• Metabolic stress can cause widespread accumulation of cap-unmethylated RNAs, linking capping to cellular stress responses.
• CRISPR knockout, point-mutation, and knock-in models enable functional dissection of capping enzymes in disease and development.
Description
7-methylguanosine mRNA capping (GO:0006370) is the co-transcriptional modification that adds a 7-methylguanosine cap to the 5' end of nascent RNA polymerase II transcripts. This cap consists of an inverted m7G linked via a 5'-5' triphosphate bridge to the first transcribed nucleotide, and it can be further methylated on the ribose sugars of the first and second nucleotides to form m6,2A or m6,2G. The process is essential for mRNA stability, nuclear export, and translation initiation, and it distinguishes mature mRNAs from other RNA species. Researchers study this term to understand gene expression regulation, viral immune evasion, and stress responses. Defects in capping are linked to developmental abnormalities and disease, making it a target for therapeutic intervention.
7-methylguanosine mRNA capping At A Glance
| GO ID | GO:0006370 |
|---|---|
| GO term | 7-methylguanosine mRNA capping |
| Ontology | biological_process |
| Synonym | 5' end capping, 5'-end mRNA processing, 5'-end processing, 5' mRNA capping, mRNA capping |
| Major function | Addition of the m7G cap to nascent mRNA for stability, export, and translation initiation |
| Key enzymes | RNA triphosphatase, RNA guanylyltransferase, RNA guanine-N7 methyltransferase |
| Cap structure | m7G(5')ppp(5')X with optional m6,2A or m6,2G methylations |
| Cellular location | Nucleus, co-transcriptional with RNA polymerase II |
What Is GO:0006370?
GO:0006370 describes the sequence of enzymatic reactions that add the mRNA 5' cap structure, an inverted 7-methylguanosine linked via a 5'-5' triphosphate bridge (m7G(5')ppp(5')X) to the first transcribed residue of a nascent transcript. Additional methylations can occur on the ribose sugars of the first and second nucleotides adjacent to the m7G cap, forming N6,2'-O-dimethyladenosine (m6,2A) and N6,2'-O-dimethylguanosine (m6,2G). This process is synonymous with 5' end capping, 5'-end mRNA processing, and mRNA capping.
Why Is 7-methylguanosine mRNA capping Important in Cell Biology?
7-methylguanosine mRNA capping is a critical checkpoint in gene expression because the cap determines mRNA fate from transcription to translation. Without a proper cap, transcripts are recognized as foreign or defective and are rapidly degraded, as shown in Toxoplasma gondii where loss of capping leads to transcript instability and parasite death. In humans, capping is co-transcriptional and coupled to RNA polymerase II elongation, and its dysregulation is associated with cancer and developmental disorders. Viruses often encode their own capping enzymes or steal host caps to evade immune detection, making capping a target for antiviral drugs. Metabolic stress can cause accumulation of cap-unmethylated RNAs, revealing a dynamic layer of regulation. Thus, understanding GO:0006370 is essential for basic RNA biology and therapeutic development.
• The m7G cap is required for mRNA stability and prevents degradation by exonucleases.
• Capping is essential for efficient translation initiation via cap-binding proteins.
• Defects in capping enzymes cause transcript homeostasis failure and cell death in parasites.
• Viruses with non-canonical caps can evade innate immune recognition.
• Metabolic stress induces widespread cap-unmethylated RNAs, linking capping to stress responses.
• Capping is coupled to transcription and influenced by oncogenes like Myc.
• Plant capping enzymes modulate abscisic acid responses, showing conserved roles in development.
• Capping is a target for antiviral and antiparasitic drug development.
• CRISPR screens can identify capping factors required for cell fitness.
• Engineered multicapped mRNAs and circular RNAs enhance translation for therapeutics.
What Happens During 7-methylguanosine mRNA capping?
Step 1: RNA triphosphatase removes the gamma-phosphate
In simple terms: The first step trims the RNA's 5' end by removing a phosphate group.
The capping process begins with RNA triphosphatase, which hydrolyzes the 5' gamma-phosphate of the nascent transcript to generate a 5' diphosphate end. This step is essential for preparing the RNA for guanylyltransferase activity. In Toxoplasma gondii, RNA triphosphatase-mediated capping is required for transcript homeostasis and survival. The enzyme acts co-transcriptionally, and its activity is tightly coupled to RNA polymerase II elongation.
Step 2: RNA guanylyltransferase adds GMP
In simple terms: A guanine nucleotide is attached to the RNA's 5' end via a special 5'-5' linkage.
RNA guanylyltransferase (also called capping enzyme) transfers GMP from GTP to the 5' diphosphate RNA, forming the 5'-5' triphosphate bridge. This creates the G(5')ppp(5')X structure. The reaction is conserved from yeast to humans and is essential for cap formation. In Arabidopsis, RNMT1-mediated capping modulates abscisic acid responses, indicating functional conservation in plants.
Step 3: RNA guanine-N7 methyltransferase methylates the cap
In simple terms: A methyl group is added to the guanine to form the mature 7-methylguanosine cap.
The final step is catalyzed by RNA guanine-N7 methyltransferase, which uses S-adenosylmethionine to methylate the guanine at the N7 position, yielding m7G. This methylation is critical for cap function, as unmethylated caps are poorly recognized by translation initiation factors and are associated with stress responses. Metabolic stress can lead to widespread accumulation of cap-unmethylated RNAs, highlighting the regulatory importance of this step.
Additional methylations: m6,2A and m6,2G
In simple terms: Sometimes the first or second nucleotide after the cap gets an extra methyl group.
After m7G formation, additional methylations can occur on the ribose sugars of the first and second nucleotides, forming N6,2'-O-dimethyladenosine (m6,2A) or N6,2'-O-dimethylguanosine (m6,2G). These modifications can influence mRNA stability and translation efficiency. Engineered multicapped mRNAs and capped circular RNAs exploit these structures to augment translation.
Non-canonical caps and viral strategies
In simple terms: Some viruses make unusual caps to hide from the immune system.
Vaccinia virus mRNAs containing long 5'-poly(A)-leaders lack a canonical 5'-methylguanosine cap, demonstrating that viruses can evade immune detection by altering cap structures. Enzymatic assays to explore viral mRNA capping machinery have been developed to study these mechanisms. Such non-canonical caps are potential targets for antiviral therapies.
Key Genes Involved in GO:0006370 7-methylguanosine mRNA capping
The following genes and proteins are central to 7-methylguanosine mRNA capping, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNGTT | RNA guanylyltransferase and 5'-phosphatase; adds GMP to RNA | Core capping enzyme; knockout causes transcript instability |
| RNMT | RNA guanine-N7 methyltransferase; methylates the cap | Essential for m7G formation; stress-sensitive |
| RNGTT (Toxoplasma) | RNA triphosphatase; removes gamma-phosphate | Parasite survival; drug target |
| RNMT1 (Arabidopsis) | m7G capping of mRNA | Modulates ABA response in plants |
| DXO1 (Arabidopsis) | Cap homeostasis; decapping | Regulates ABA response |
| MYC | Oncogene; regulates capping enzyme expression | Links capping to cancer and transcription |
| POLR2A | RNA polymerase II; couples transcription to capping | Capping occurs co-transcriptionally |
| NCBP1 | Cap-binding protein; binds m7G cap | Translation initiation and export |
| NCBP2 | Cap-binding protein; binds m7G cap | Translation initiation |
| EIF4E | Cap-binding translation initiation factor | Translation efficiency |
| Vaccinia capping enzyme | Viral capping enzyme; adds non-canonical caps | Immune evasion; antiviral target |
| SAM | Methyl donor for N7 methylation | Cofactor for RNMT |
| GTP | Substrate for guanylyltransferase | Provides GMP for cap |
| RNA triphosphatase (viral) | Removes gamma-phosphate in viruses | Antiviral target |
| RNMT-activating miniprotein (RAM) | Activates RNMT | Regulates methylation |
| Cap-specific 2'-O-methyltransferase | Adds m6,2A/m6,2G | Fine-tunes translation |
How Is 7-methylguanosine mRNA capping Regulated?
7-methylguanosine mRNA capping is regulated at multiple levels. The process is co-transcriptional and coupled to RNA polymerase II elongation, meaning transcription factors and oncogenes like Myc can influence capping efficiency. Metabolic stress induces widespread accumulation of cap-unmethylated RNAs, suggesting that nutrient sensing pathways regulate the methylation step. In plants, DXO1 and RNMT1 mediate m7G capping to modulate abscisic acid responses, indicating hormonal regulation. Viral proteins can hijack or inhibit capping machinery to evade immunity. Additionally, the availability of S-adenosylmethionine (SAM) as a methyl donor can limit N7 methylation under metabolic stress.
7-methylguanosine mRNA capping and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYC | Cancer (MYC-driven) | Knockout or overexpression in cancer cell lines |
| RNGTT | Parasitic infection (Toxoplasma) | Conditional knockout in T. gondii |
| RNMT | Metabolic stress response | Point mutation of catalytic residue |
| Vaccinia capping enzyme | Viral immune evasion | Infection with mutant virus |
| RNMT1/DXO1 | Plant development (ABA response) | Arabidopsis knockout |
Cancer
The oncogene MYC regulates mRNA capping enzyme expression, linking capping to cancer cell proliferation and survival. Dysregulated capping can promote oncogenic translation and mRNA stability, making capping enzymes potential therapeutic targets in MYC-driven cancers.
Parasitic infections
In Toxoplasma gondii, RNA triphosphatase-mediated mRNA capping is essential for maintaining transcript homeostasis and parasite survival, identifying capping as a drug target for toxoplasmosis.
Viral immune evasion
Vaccinia virus mRNAs containing long 5'-poly(A)-leaders lack a canonical 5'-methylguanosine cap, allowing the virus to evade innate immune detection. This highlights capping as a battleground in host-pathogen interactions.
Metabolic stress and disease
Metabolic stress causes widespread accumulation of cap-unmethylated RNAs, which may contribute to cellular dysfunction in metabolic disorders. This links capping to stress-responsive pathways and disease pathology.
From 7-methylguanosine mRNA capping-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is RNGTT essential for cell viability? | CRISPR knockout in human cell lines |
| Does a point mutation in RNMT abolish methylation? | CRISPR point mutation (catalytic dead) |
| Can tagged RNMT be used for localization? | Knock-in of fluorescent tag |
| Does overexpression of MYC increase capping? | Overexpression of MYC in cancer cells |
| What genes regulate capping under stress? | CRISPR library screening |
| Can engineered caps enhance translation? | Multicapped mRNA transfection |
How to Study the 7-methylguanosine mRNA capping Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript abundance and 5' end mapping | Global capping efficiency |
| Enzymatic assay | Triphosphatase, guanylyltransferase, methyltransferase activity | Viral capping machinery |
| Ribo-seq | Translation efficiency | Cap-dependent translation |
| Mass spectrometry | Protein interactions and modifications | Capping complex composition |
| CRISPR screen | Gene essentiality and fitness | Identify capping regulators |
| Fluorescence microscopy | Subcellular localization | Nuclear capping enzymes |
| Cap immunoprecipitation | m7G-cap enriched RNAs | Cap-unmethylated RNA detection |
RNA sequencing and cap analysis
RNA-seq and specialized cap analysis methods (e.g., CAGE, Cap-seq) can map 5' ends and quantify capping efficiency. Metabolic stress-induced cap-unmethylated RNAs were detected using such approaches. These methods reveal transcriptome-wide changes in capping.
Enzymatic assays for capping activity
In vitro enzymatic assays using recombinant capping enzymes and radiolabeled GTP can measure triphosphatase, guanylyltransferase, and methyltransferase activities. These assays are used to study viral capping machinery and screen inhibitors.
Ribosome profiling (Ribo-seq)
Ribo-seq measures translation efficiency and can reveal how cap structures affect initiation. Multicapped mRNAs and circular RNAs show enhanced translation, which can be quantified by Ribo-seq.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry can identify proteins interacting with capping enzymes, such as RNMT and its activator RAM. This helps define the capping complex and its regulation.
How CRISPR Can Be Used to Study GO:0006370 7-methylguanosine mRNA capping
Knockout
CRISPR knockout of capping enzymes such as RNGTT or RNMT can reveal their essentiality. In Toxoplasma gondii, knockout of RNA triphosphatase led to transcript instability and parasite death. In human cells, knockout of MYC-regulated capping enzymes affects proliferation.
Point Mutation
Point mutations in catalytic residues of RNMT or RNGTT can abolish enzymatic activity without affecting protein stability. Such models are useful to separate catalytic from scaffolding functions. For example, mutation of the SAM-binding site in RNMT prevents N7 methylation.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) into endogenous capping enzyme loci allows visualization and purification of native complexes. This approach has been used to study RNMT localization and interactions.
Overexpression
Overexpression of capping enzymes or oncogenes like MYC can increase capping activity and alter translation. This is relevant for cancer models where MYC drives capping enzyme expression. Overexpression of viral capping enzymes can also be used to study immune evasion.
How EDITGENE Supports 7-methylguanosine mRNA capping Research
Researchers studying 7-methylguanosine mRNA capping-related genes often need to determine whether a candidate gene is causally involved in RNA stability, translation, or disease. EDITGENE provides CRISPR-based cell models and screening services to dissect these mechanisms with precision.
Contact EDITGENE today to design your custom CRISPR model for 7-methylguanosine mRNA capping research.
Frequently Asked Questions About 7-methylguanosine mRNA capping
What is 7-methylguanosine mRNA capping?
It is the enzymatic addition of a 7-methylguanosine cap to the 5' end of nascent mRNA via a 5'-5' triphosphate bridge, essential for stability and translation.
What genes are involved in 7-methylguanosine mRNA capping?
Key genes include RNGTT, RNMT, MYC, and in plants RNMT1 and DXO1.
What is the GO ID for 7-methylguanosine mRNA capping?
The GO ID is GO:0006370.
Why is mRNA capping important?
It protects mRNA from degradation, facilitates nuclear export, and enables efficient translation initiation.
How is mRNA capping regulated?
It is co-transcriptional, influenced by oncogenes like MYC, and sensitive to metabolic stress and SAM availability.
What diseases are linked to mRNA capping defects?
Cancer, parasitic infections, and viral immune evasion are associated with capping dysregulation.
What methods study mRNA capping?
RNA-seq, enzymatic assays, Ribo-seq, and mass spectrometry are commonly used.
Can CRISPR be used to study mRNA capping?
Yes, knockout, point mutation, knock-in, and overexpression models are available to dissect capping gene function.
What is the cap structure?
It is m7G(5')ppp(5')X, with optional m6,2A or m6,2G methylations on the first two nucleotides.
Do viruses have mRNA capping?
Some viruses encode their own capping enzymes or use non-canonical caps to evade immunity, as seen in vaccinia virus.
Conclusion
7-methylguanosine mRNA capping (GO:0006370) is a fundamental biological process that ensures mRNA stability, export, and translation. Its dysregulation is linked to cancer, parasitic infections, and viral immune evasion, making it a rich area for therapeutic targeting. Advances in CRISPR modeling and RNA analysis continue to uncover new layers of capping regulation, including stress-induced cap-unmethylated RNAs. EDITGENE provides comprehensive CRISPR services to accelerate research on this critical pathway.
References
- 1. Chen H et al.. 2025. Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation.. Nat Biotechnol 43(7):1128-1143 PMID: 39313647
- 2. Dunn S et al.. 2015. Myc and mRNA capping.. Biochim Biophys Acta 1849(5):501-5 PMID: 24681440
- 3. Fukuchi K et al.. 2026. Internal cap-initiated translation for efficient protein production from circular mRNA.. Nat Biotechnol 44(1):120-132 PMID: 39972222
- 4. Kasprzyk R et al.. 2021. Enzymatic Assays to Explore Viral mRNA Capping Machinery.. Chembiochem 22(23):3236-3253 PMID: 34291555
- 5. Liang S et al.. 2026. Arabidopsis DXO1- and RNMT1-Mediated m(7)G Capping of mRNA Modulates ABA Response.. Plant Cell Environ 49(8):5358-5372 PMID: 41992538
- 6. Aswale KR et al.. 2025. RNA triphosphatase-mediated mRNA capping is essential for maintaining transcript homeostasis and the survival of Toxoplasma gondii.. Nat Commun 16(1):5452 PMID: 40595475
- 7. Vopálenský V et al.. 2025. Vaccinia virus mRNAs containing long 5'-poly(A)-leaders lack a canonical 5'-methylguanosine cap.. Nat Commun 16(1):11340 PMID: 41430051
- 8. Xing Z et al.. 2026. Metabolic stress reveals widespread accumulation of cap-unmethylated RNAs.. bioRxiv PMID: 41867715
